会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Methods of screening for a compound that enhances thermogenesis
    • 筛选增强产热的化合物的方法
    • US07396642B2
    • 2008-07-08
    • US10483627
    • 2002-07-17
    • Kazuyoshi YamaokaKenichiro TakagiKenichiro KataokaMasanori YamamotoToshihiro Chikanishi
    • Kazuyoshi YamaokaKenichiro TakagiKenichiro KataokaMasanori YamamotoToshihiro Chikanishi
    • C12Q1/00C12Q1/68G01N33/53
    • G01N33/5079G01N33/6872
    • The present invention provides a method for screening a substance having a thermogenesis enhancing effect containing a compound having an effect activating PPAR δ, an agent containing the compound, and an agent having antidiabetic, antiobestic or visceral accumulated fat-lowering function.The present invention provides an agent containing a compound having an effect activating PPAR δ, which is a peroxisome proliferator activated receptor, and having effects which enhances nonshivering thermogenesis (nST), specifically enhances uncoupling respiration in mitochondria of cells in an adipose tissue or the like, or proton leak in inner membranes of mitochondria, and increases the amount of expression of UCP1, and provides an antidiabetic agent, an antiobestic gent and a visceral accumulated fat-lowering agent containing the compound. Further, the present invention provides a method for screening the compound by measuring a PPAR δ activating effect.
    • 本发明提供一种筛选具有生发增强效果的物质的方法,其含有具有活化PPARδ的作用的化合物,含有该化合物的药剂和具有抗糖尿病,抗胆固醇或内脏积累的降脂功能的药剂。 本发明提供了含有具有活化PPARδ作用的化合物的化合物,其是过氧化物酶体增殖物激活受体,并且具有增强非发热生成(nST)的作用,特别地增强脂肪组织等中的细胞的线粒体中的解偶联呼吸 或线粒体内膜中的质子泄漏,并增加UCP1的表达量,并提供含有该化合物的抗糖尿病药,抗胆碱剂和内脏累积降脂剂。 此外,本发明提供了通过测量PPARδ激活效应来筛选化合物的方法。